Concepedia

Ang Li

AL

Statistics

Publications

4

Citations

138

H-Index

4

Active since

2010

Affiliations

Bristol-Myers Squibb (United States)(Current)

Ang Li is an author at Bristol-Myers Squibb (United States) specializing in medicine, cancer research, and cell biology.

ORCID

Top concepts

Publications per year

2010–2021

4

Publications

4

Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3–COX2-dependent pathway

Ang Li, Ping Chen, Ye Leng et al. · Oncogene · 2018 · 83 citations

, , +14

Safety profile of nivolumab administered as 30-min infusion: analysis of data from CheckMate 153

David Waterhouse, Leora Horn, Craig H. Reynolds et al. · Cancer Chemotherapy and Pharmacology · 2018 · 19 citations

, , +9

Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cells

Xinyu Huang, Hongcheng Wang, Zhou Yuan et al. · Acta Pharmacologica Sinica · 2010 · 18 citations · Full text

, , +8

Three-year follow-up and patient-reported outcomes from CheckMate 078: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer

Jianhua Chang, Yi‐Long Wu, Shun Lü et al. · Lung Cancer · 2021 · 18 citations

, , +9

1–4 of 4